clinical_trials
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
Confidence88·multiple reportsImportance90NP-EVT-20261110-877343F
PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.
Read the original at the primary source
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
Jason Mast · 11/10/2026, 12:05:00 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —